The CYP3A biomarker 4β‐hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation - Concepedia

Concepedia

Publication | Open Access

The CYP3A biomarker 4β‐hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation

DOI Full Paper Access

18

Citations

35

References

2017

Year

Elisabet Størset, Kristine Hole, Karsten Midtvedt, Stein Bergan, Espen Molden, Anders Åsberg

British Journal of Clinical Pharmacology

Abstract

4βOHC does not appear to have a clinical potential to improve individualization of tacrolimus doses early after kidney transplantation.

References

	Year	Citations

Page 1